Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Michal, Andel"'
Autor:
Stepanka Pruhova, Petra Dusatkova, Pavel J. Kraml, Michal Kulich, Zdena Prochazkova, Jan Broz, Jaroslav Zikmund, Ondrej Cinek, Michal Andel, Oluf Pedersen, Torben Hansen, Jan Lebl
Publikováno v:
International Journal of Endocrinology, Vol 2013 (2013)
Aim. GCK-MODY is an autosomal dominant form of diabetes caused by heterozygous mutations in the glucokinase gene leading to a lifelong mild hyperglycemia. The risk of macrovascular complications is considered low, but studies are limited. We, therefo
Externí odkaz:
https://doaj.org/article/6e64715ebc0d4de5a9a37b9e9200fbca
Autor:
Petr Busek, Helena Posova, Michal Andel, Pavel Škrha, Jana Potockova, Aleksi Sedo, Lucie Sromova
Publikováno v:
Diabetes Research and Clinical Practice. 118:183-192
Aim To assess intraindividually the effects of DPP-IV inhibition on the subpopulations of immune cells in type 2 diabetes mellitus (DM2) patients during the course of treatment with sitagliptin. Methods In this open label non-randomized observational
Autor:
Mihail Boyanov, Lea Duvnjak, Tsvetalina Tankova, Andrej Janez, Krzysztof Strojek, Adam Kretowski, Marcin Zychma, Iwona Tarnowska, Leszek Czupryniak, Martin Haluzik, Michal Andel, Nebojsa Lalic, Péter Kempler, László Madácsy
Publikováno v:
Diabetes Therapy
INTRODUCTION: The aim of this study was to determine the level of awareness of hypoglycemia, the level of fear for hypoglycemia, and the response to hypoglycemic events among insulin-treated diabetes patients from Central and Eastern Europe (CEE). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241ad1b250a2df371c4144bca2c229e5
https://doi.org/10.1007/s13300-018-0388-2
https://doi.org/10.1007/s13300-018-0388-2
Autor:
Michal, Andel, Pavel, Skrha, Pavel, Kraml, Jana, Potockova, Iva, Hoffmanova, Elena, Silhova, Josef, Fontana, Anna, Richterova, Martin, Gadiredi, Petr, Busek, Lucie, Sromova, Aleksi, Šedo
Publikováno v:
Vnitrni lekarstvi. 62(6)
We present the results of an independent, drug company-unsupported follow-up of patients with type 2 diabetes mellitus (T2DM) treated with the dipeptidyl peptidase 4 inhibitor sitagliptin. 29 patients (16 men, 13 women) used sitagliptin 100 mg daily
Autor:
Petr Syrovatka, Michal Andel, Katarina Hulikova, Kraml P, Lenka Fialová, Jana Potockova, Martin Vejrazka, Jirina Crkovska
Publikováno v:
European Journal of Clinical Investigation. 41:846-853
Eur J Clin Invest 2011; 41 (8): 846–853 Abstract Background The aim of our study was to assess the impact of increased iron stores on the presence of asymptomatic atherosclerosis in a cohort of healthy men. We anticipated that higher iron stores wo
Publikováno v:
Journal of Renal Nutrition. 19:95-100
Successful kidney transplantation leads to restoration of renal function. Some metabolic disorders from chronic renal failure may persist and new metabolic abnormalities can develop (obesity, diabetes, hypertension, bone disease, and anemia). Additio
Autor:
Petr Syrovatka, Berit Hippe, Jutta Zwielehner, Yoshiyuki Matsubara, Pilar Galan, L. Teixeira, Manuel Bueno, Jana Potockova, Kraml P, Lin Yang, Sonia Gómez-Martínez, Serge Hercberg, Koichiro Kano, Marise Lazaretti-Castro, Michael Handschur, D.D. Tsiftsis, G Mamalakis, Luis Moreno, Jirina Crkovska, Francisco B. Ortega, Idoia Labayen, Daisuke Kondo, Martin Vejrazka, Sébastien Czernichow, Gloria Bueno, E. de Bree, Hideo Mugishima, Linda D.F. Moreira-Pfrimer, Ibrahim Elmadfa, Michal Andel, Markos Daskalakis, Motoni Kadowaki, Carlos Redondo-Figuero, Taro Matsumoto, Ibrahim M.D. Khatib, Elias Sanidas, J. Askoxylakis, Roman Thaler, Lenka Fialová, Kathrin Liszt, Antony Kafatos, Alexander G. Haslberger, George Tsibinos, Márcia A.C. Pedrosa, Christos M. Hatzis
Publikováno v:
Annals of Nutrition and Metabolism. 54:I-IV
Autor:
P. Novota, Katarina Kolostova, Pavel Weber, Jan Novák, Pavlina Cejkova, Milena Černá, D. Novakova, E. Zdarsky, Michal Andel, Petr Kučera
Publikováno v:
International Journal of Immunogenetics. 35:133-140
Both the human leucocyte antigen (HLA) DRB1 and the HLA DQB1 gene loci play a role in the development and progression of autoimmune diabetes mellitus (T1DM). Similarly, the insulin promoter variable number tandem repeats (INS-VNTR) polymorphism is al
Autor:
Jana, Urbanova, Michal, Andel, Jana, Potockova, Josef, Klima, Jan, Macek, Pavel, Ptacek, Vaclav, Mat'oska, Tereza, Kumstyrova, Petr, Heneberg
Publikováno v:
Current pharmaceutical design. 21(39)
Sulfonylurea derivatives are widely used for clinical treatment of human subjects with Maturity Onset Diabetes of the Young (MODY) caused by mutations in HNF-1α or HNF-4α despite the mechanism leading to their hypersensitivity is incompletely under
Publikováno v:
Lipids. 50(10)
Unsaturated free fatty acids (FFA) are able to prevent deleterious effects of saturated FFA in skeletal muscle cells although the mechanisms involved are still not completely understood. FFA act as endogenous ligands of peroxisome proliferator-activa